Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET

• Päätekijät: Hiroki Matsumoto (Tekijä), Chika Igarashi (Tekijä), Tomoko Tachibana (Tekijä), Fukiko Hihara (Tekijä), Mitsuhiro Shinada (Tekijä), Atsuo Waki (Tekijä), Sei Yoshida (Tekijä), Kenichiro Naito (Tekijä), Hiroaki Kurihara (Tekijä), Makoto Ueno (Tekijä), Kimiteru Ito (Tekijä), Tatsuya Higashi (Tekijä), Yukie Yoshii (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2022-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Detecting tumor lesions <1 cm in size using current imaging methods remains a clinical challenge, especially in pancreatic cancer. Previously, we developed a method to identify pancreatic tumor lesions ≥3 mm using positron emission tomography (PET) with an intraperitoneally administered <sup&g...